| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.5M | +81.9% |
| SG&A Expense | $1.6M | +50.7% |
| Operating Income | -$8.0M | -74.9% |
| Net Income | -$7.8M | -71.2% |
| EPS (Basic) | -$0.61 | -74.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.5M | -50.5% |
| Total Assets | $13.5M | -50.5% |
| Current Liabilities | $263K | -31.7% |
| Total Liabilities | $263K | -31.7% |
| Stockholders' Equity | $13.2M | -50.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.2M | -44.5% |
| Financing Cash Flow | -$7.5M | -365.8% |